Call Us: 1 (800) 647 6100

XYMOGEN
6900 Kingspointe Pkwy, Orlando, FL 32819, US

Open in Google Maps

Email: info@xymogen.com

XYMOGEN
6900 Kingspointe Pkwy, Orlando, FL 32819, US

Open in Google Maps

Go

XYMOGEN News

People First Culture

Eve Plews, XYMOGEN Founding Board Member 1947-2018

  •  by admin
  •  9/11/2018 12:00:00 AM


XYMOGEN is sad to announce that founding board member, Eve Plews, passed away Saturday, September 1, 2018

Read More  

New Sales Record, Successful Event for XYMOGEN

  •  by admin
  •  6/22/2018 12:00:00 AM


XYMOGEN® does it again! For two months in a row, the company has beaten its own sales records. May’s sales topped $11 million, the highest in the company’s more than 25-year history, compared to April’s already high-performing sales at $10 million. May also saw a new daily sales record of over $500,000 a day, which is a 30 percent increase over 2017’s daily sales.

Read More  

XYMOGEN Reports Highest Monthly Sales Ever

  •  by admin
  •  5/23/2018 12:00:00 AM


XYMOGEN® is proud to announce that April was the company’s highest-grossing sales month in its 25+ year history, garnering a total of $10 million in sales.

Read More  

XYMOGEN Reaches $100M in Revenues, Celebrates 20th Exclusive Showcase for Healthcare Practitioners

  •  by admin
  •  1/29/2018 12:00:00 AM


January 29, 2018—XYMOGEN®, the leader in exclusive and proprietary professional nutraceutical formulas, is proud to announce that it surpassed the $100 million milestone in revenues for fiscal year 2017.

Read More  

XYMOGEN Awarded 2017 Central Florida Manufacturer of the Year

  •  by admin
  •  10/30/2017 12:00:00 AM


On Oct. 12, 2017, XYMOGEN was honored with the prestigious 2017 Manufacturers Association of Central Florida’s (MACF) Award of Excellence for Manufacturer of the Year in the large manufacturer size category.

Read More  

XYMOGEN in Elite Group, Named Tenth Time to Inc. 5000

  •  by Admin
  •  9/28/2017 12:00:00 AM


Orlando-based health sciences company XYMOGEN has recently been recognized for the tenth time on Inc. Magazine’s Inc. 5000 list as one of the fastest growing and best-run private companies in the nation

Read More  

XYMOGEN Leads Amazon Elements on Supplement Transparency

  •  by admin
  •  3/23/2017 12:00:00 AM


XYMOGEN is way ahead of the supplements transparency curve. Recently, Amazon Elements, the mega internet retailer’s private label brand, has included four dietary supplements, in an effort, it states, to bring more transparency and safety to these products. As the only exclusive practitioner-channel supplements formula company, XYMOGEN has been offering this transparency to its customers for years.

Read More  

XYMOGEN Makes History

  •  by admin
  •  12/7/2016 12:00:00 AM


XYMOGEN, in partnership with FON Consulting, publishes a chronicle of the dramatic rise and influence of integrative healthcare.

Read More  

XYMOGEN®’s Omega MonoPure™ Delivers Three Times More Bioavailable Omega-3s Than Other Products on the Market

  •  by admin
  •  10/4/2016 12:00:00 AM


ORLANDO, Fla. — October 4, 2016 — XYMOGEN® rocks the nutraceutical industry yet again with the introduction of its patented and exclusive MonoPure™ line of omega-3 EPA + DHA products. What makes MonoPure™ so different from other omega-3 EPA + DHA products is that it delivers an easy to digest highly concentrated omega-3 fish oil, which when studied clinically was shown to be three times more absorbable* than ethyl ester (EE) fish oil.

 

Read More  

XYMOGEN to supply multivitamin preparation for prestigious, federally funded clinical Trial to Assess Chelation Therapy (TACT2)

  •  by admin
  •  9/28/2016 12:00:00 AM


ORLANDO, Fla. (September 27, 2016)—XYMOGEN is proud to announce that it has been chosen by Mount Sinai Medical Center of Florida and the Duke Clinical Research Institute to manufacture and supply the oral vitamin and mineral preparations that will be tested in the second Trial to Assess Chelation Therapy (TACT2), a $37M federally sponsored clinical trial.

Read More  

XYMOGEN Ranked Among the Nation's Fastest Growing Private Companies for the Ninth Time

  •  by admin
  •  9/23/2016 12:00:00 AM


Orlando, FL. – September 22, 2016 – Orlando-based health sciences company XYMOGEN has recently been recognized for the ninth time on Inc. Magazine’s Inc. 5000 list as one of the fastest growing and best-run private companies in the nation.

Read More  

Buyer Beware: XYMOGEN Not Sold on Amazon.com

  •  by admin
  •  9/21/2016 12:00:00 AM


XYMOGEN, a leading functional medicine manufacturer, is one of several companies that have purposely sidestepped doing business on the mega-Internet sales site Amazon.com. To highlight this turn of events, Birkenstock, the icon of environmental consciousness and centuries of shoemaking expertise, recently stated that its products will no longer be sold on Amazon.com.

Read More  

Mandated Label Change to Supplement Facts and Nutrition Facts Boxes

  •  by admin
  •  9/9/2016 12:00:00 AM


July 26, 2018 is circled on the XYMOGEN calendar. On or before this date, we—like every food and supplement manufacturer—will have completed the task of modifying each and every XYMOGEN formula label to comply with the new rules set forth by the US Food and Drug Administration (FDA) in the Federal Register under "Food Labeling: Revision of the Nutrition and Supplement Facts Labels." These rules took effect on July 26, 2016.

Read More  

Should Practitioner-Channel Brands Make Peace with Amazon?

  •  by admin
  •  7/11/2016 12:00:00 AM


Read the following article  from Nutraceuticals World for more information from Brian Blackburn as to why XYMOGEN is opposed to online retail sales of professional formulas.

Read More  

XaQuil® XR Named Product of the Year by NutraIngredients

  •  by admin
  •  6/20/2016 12:00:00 AM


XaQuil® XR the newest product from XYMOGEN's medical food* line, PharmaceutiX® , is one of the most exciting products of the year, and the company is racking up the awards to prove it.

Read More  

Max Heart has been Discontinued

  •  by admin
  •  6/13/2016 12:00:00 AM


With new understanding, research and testing comes new breakthroughs*. That's why we are letting you know we will no longer be carrying MaX Heart™.

Read More  

XaQuil® XR with Gnosis’ Quatrefolic® is finalist at NutraIngredients Awards 2016

  •  by admin
  •  5/9/2016 12:00:00 AM


Gnosis S.p.A. April 2016 Newsletter

Quatrefolic® in partnership with XYMOGEN® is short-listed for NutraIngredients Awards 2016!

The partnership between Gnosis and the US nutraceutical producer XYMOGEN® is proving innovative! XYMOGEN’s XaQuil®XR, finished oral dose product containing Gnosis’ Quatrefolic®, has been selected as a finalist of NutraIngredients Awards 2016 for the Finished Product of the Year – Medical Food category.

Read More  

XYMOGEN Earns Prestigious Australian TGA Certification

  •  by admin
  •  2/24/2016 12:00:00 AM


ORLANDO, Fla. – DAY, 24, February 2016 — XYMOGEN, the Orlando-based health sciences company, has earned Australia’s prestigious certification from the Therapeutic Goods Administration (TGA), that country’s equivalent to the U.S. Federal Drug Administration.

Read More  

Orlando Business Journal Recognizes Brian Blackburn

  •  by admin
  •  10/13/2015 12:00:00 AM


Brian Blackburn, CEO of XYMOGEN named one of Orlando Business Journal's 2015 CEO of the Year Honorees.

Read More  

XYMOGEN Surpasses Seven Million Dollar Month Milestone

  •  by Admin
  •  2/26/2015 12:00:00 AM


ORLANDO, Fla. -- February 26, 2015 -- Orlando-based health sciences company XYMOGEN has announced it surpassed the Seven Million Dollar Month Revenue Milestone for January-2015. This represents the third consecutive January in which the company surpassed a Million-Dollar Milestone, reaching $5 million and $6 million in 2013 and 2014, respectively.

Read More  

XYMOGEN Responds to New York Times Article on the New York Attorney General Investigation

  •  by Admin
  •  2/4/2015 12:00:00 AM


I am writing you in response to the New York AG investigation of herbal supplements sold at retail outlets (GNC, Walgreens, Walmart, and Target).

Read More  

XYMOGEN Ranked Among the Nation's Fastest Growing Private Companies for a Seventh Time

  •  by Admin
  •  9/2/2014 12:00:00 AM


Orlando-based health sciences company XYMOGEN announced today that it has been recognized for the seventh time on Inc. Magazine’s Inc. 5000 list as one of the fastest growing and best run private companies in the nation.

Read More  

XYMOGEN Launches ALAmax Protect to Help Support Cardio Metabolic Health

  •  by Admin
  •  8/5/2014 12:00:00 AM


Orlando-based health-sciences company XYMOGEN announced that ALAmax Protect™, the latest formula in the company’s line of professional formulas to support cardio metabolic health, is now available.

Read More  

XYMOGEN's Stance on Niacin

  •  by Admin
  •  7/17/2014 12:00:00 AM


Once again, the major media outlets are making a major splash with the negative news about niacin based on the HPS2-THRIVE study – first announced in March of 2013, and now again with the full publication of the study in the New England Journal of Medicine.

Read More  

Instagram

Latest Tweets

Become a XYMOGEN Insider

Join our mailing list.
Interested in receiving special offers, access to exclusive webinars, seminars, up-to-date industry news, and so much more? Sign up for our FREE newsletter and get started today!

BONUS: As a XYMOGEN Insider, you will also get a FREE digital copy of The Rise of Integrative Health & Medicine—The Milestones: 1963–Present by Glenn Sabin and Taylor Walsh.

Subscribe

Global Headquarters
Contact Us

Send

© 2018 XYMOGEN®. All right reserved.

*These statements have not been evaluated by the Food and Drug Administration. These products are not intended to diagnose, treat, cure, or prevent any disease.